One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2019-128683
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 1 |
Affiliation: University Cancer Center Hamburg, Universität Hamburg, University Medical Center Hamburg-Eppendorf, University of Parma, Ospedale di Parma, Hannover Medical School, University of Iowa, BerGenBio (Norway), University Hospital Ulm, Ospedale Vito Fazzi, University Hospital Frankfurt, Goethe University Frankfurt, Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo, University of Genoa, Ospedale Policlinico San Martino, Haukeland University Hospital, The University of Texas MD Anderson Cancer Center, University of Bergen
Durable Responses Observed in Elderly AML Patients Unfit for Intensive Chemotherapy with First-in Class Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with LDAC: Phase II Open-Label Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
